Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease (PR Newswire)

biz.yahoo.com | Oct 8, 2008

Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease. - Exploratory study shows clinical improvement in patients with pulmonary arterial hypertension (PAH)

http://biz.yahoo.com/prnews/081008/ny37606.html?.v=1

Systemic sclerosis: hypothesis-driven treatment strategies : The Lancet

www.thelancet.com

Because these drugs have improved function and quality of life and have increased survival rates, they can truly be classified as disease-modifying compounds.

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(06)68737-0/fulltext

Heart Disease Weekly (2000-07-02) | NewsRx

NewsRx also is available at Factiva, LexisNexis, ProQuest, Westlaw, Dialog, NewsEdge, InfoDesk, and Dow Jones.

http://www.newsrx.com/newsletters/Heart-Disease-Weekly/2000-07-02.html

Bosentan in mild pulmonary hypertension – Authors' reply : The Lancet

www.thelancet.com

Mart van der Plas and colleagues propose cardiopulmonary exercise testing as an ideal method to assess maximum aerobic exercise capacity in this population of patients.

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(08)61727-4

Pure and Applied Chemistry, 1997, Volume 69, No. 3

J. de Mendoza, V. Alcázar, E. Botana, A. Galán, G. Lu, J. O. Magrans, M. Martín-Portugués, P. Prados, A. Salmerón, J. Sánchez-Quesada, C. Seel and M.

http://www.iupac.org/publications/pac/69/3

The Lancet : Volume 350, Number 9075, 9 August 1997

www.thelancet.com

The Senate has already passed a similar bill, but only allowing a surcharge of one cent per stamp. Legislators will have to reconcile these two bills.

http://www.thelancet.com/journals/lancet/issue/vol350no9075/PIIS0140-6736(00)X0050-5

Ischemic disease ? What does everyone want to know about Ischemic disease? Here's a place to start.

1: Sciagra R, Leoncini M, Cannizzaro G, Marcucci G, Pupi A, Bisi G. Predicting revascularization outcome in patients with coronary artery disease and left ventricular dysfunction (data from the SEMINATOR study). Am J Cardiol. 2002 Jun 15;89(12):1369-73.

http://www.health.xq23.com/cardiovascular_updates_cvd/Ischemic_disease.html

Medische boeken: Neurohumoral Modulators in Heart Failure, An Issue of Heart Failure Clinics,

This issue discusses the role of neurohumoral modulators in Heart Failure. The role and dosing ACE inhibitor therapy, the relevance of aldosterone antagonists, beta blockers, and novel neurohumoral antagonists are explored. Clinical trials and interventional recommendations are also presented.

http://www.geneeskundeboek.nl/leesverder.pl?isbn=9781416026648